Public awareness of the metabolic syndrome

Kronik Hastaların Metabolik Sendrom Bilgi Düzeyleri ve Farkındalıkları

Amaç: Araştırma kronik hastaların metabolik sendrom bilgi ve farkındalıklarının incelenmesi amacıyla gerçekleştirildi. Gereç ve Yöntemler: Araştırma kesitsel tarama modeli kullanılarak gerçekleştirildi. Araştırmanın verileri 14 Kasım 2023- 12 Ocak 2024 tarihleri arasında ‘Hasta Tanıtım Formu’ ve ‘Metabolik Sendrom Bilgi ve Farkındalık Ölçeği’ (MSBFÖ) kullanılarak kartopu örnekleme yöntemiyle toplandı. Tanımlayıcı istatistikler için ortalama, standart sapma, min-maks değerler, sayı ve yüzde kullanıldı. Verilerin analizinde tanımlayıcı istatistikler, Independent samples t test, One-Way ANOVA testi kullanıldı. Bulgular: Hastaların %31,7’si 50-79 yaş arası, %66,0’sı kadın, %38,3’ü üniversite ve üzeri mezunu, %53,1’i evli ve %66,0’sı şehir merkezinde yaşamaktadır. Katılımcıların %26,1’inin hipertansiyon, %21,5’inin diyabetes mellitus, %17,5’inin solunum hastalığının olduğu belirlendi. Ayrıca katılımcıların %35,6’sının hastalık süresinin 1-5 yıl arasında olduğu, %61,1’inin düzenli olarak ilaç kullandığı ve %58,4’ünün diyetine uymadığı bulundu. Hastaların MSBFÖ puan ortalaması 49,38±10,67 (min=14 ve max=70) olduğu saptandı. Hastaların yaş, eğitim durumu, çalışma durumu, hastalık süresi, düzenli ilaç kullanma ve diyetine uyma durumu ile MSBFÖ toplam puan ortalaması arasında anlamlı fark bulundu (p

Factors Associated with Improved Knowledge of Metabolic Syndrome in Female Market Traders

Metabolic syndrome (MetS) is considered to be a clustering of cardiometabolic diseases and is emerging as a public health concern. There is little evidence of this disease in market traders, and so the aim of this study was to determine the prevalence and knowledge of MetS. In this cross-sectional study, anthropometry, blood pressure and bloods were collected using standardized methods to detect the prevalence of MetS using the harmonized method in a cohort of female Ghanaian market traders (n = 338). A questionnaire documented the knowledge of MetS. Linear regression was used to investigate the factors associated with knowledge and was reported as adjusted β values. Forty-two percent (n = 142) had MetS. The overall knowledge of MetS was low, driven by education (β = 0.22, p = 0.0001), low levels of high-density lipoprotein-cholesterol (β = -0.15, p = 0.018) and affiliation with the Ewe cultural group (β = -0.19, p = 0.0004). As females working in a sedentary occupation, market traders are vulnerable to MetS. Our findings indicate the urgent need for culturally sensitive education to promote healthy behaviours.

Metabolic Syndrome Knowledge among Adults with Cardiometabolic Risk Factors: A Cross-Sectional Study

Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors. Many people may be unaware of their risk for MetS. A cross-sectional, descriptive study was conducted among hospitalized patients with at least one cardiometabolic risk factor in Mainland China. This study assessed the MetS knowledgelevel(through MetS Knowledge Scale, MSKS) and examined the potential predictors by regression analysis. A total of 204 patients aged 58.5 ± 10.1 years (55% males) participated in this study. The majority of participants had no history of hypertension (54%), dyslipidemia (79%), or diabetes (85%). However, 56% of these participants had at least three cardiometabolic risk factors, indicating the presence of MetS. The average MSKS was very low (mean = 36.7 ± 18.8, possible range = 0–100), indicating the urgent needs of MetS education in current practice. Predictors of better MetS knowledge included higher educational level, history of dyslipidemia, and normal high-density lipoprotein cholesterol (F (8, 195) = 9.39, adjusted R² = 0.192, p < 0.001). In conclusion, adults with cardiometabolic risk factors are at risk of developing MetS, but with a low level of knowledge. Specific health education on MetS should be provided, particularly for those with limited formal education or inadequate lipid management.

Assessment of the awareness and knowledge of cancer survivors regarding the components of metabolic syndrome

This study aimed to assess the prevalence of metabolic syndrome and the level of knowledge and awareness of its related conditions in a sample of cancer survivor patients. In this cross-sectional survey, a self-reported questionnaire was administered to outpatients aged >20 years with a diagnosis of cancer. This self-reported questionnaire on patient demographic characteristics, disease characteristics, and knowledge and awareness of metabolic syndrome was used as an instrument to assess patient's knowledge of metabolic syndrome. A total of 88 participants were included; of these 34.1% had metabolic syndrome, although only 6.8% of participants were diagnosed with metabolic syndrome. Over half of the participants had heard about metabolic syndrome; however, 70% of the participants did not know about the blood tests for the diagnosis of metabolic syndrome although they were aware of the physical measurements, such as weight, blood pressure, and waist circumference. The highest proportion of correct answers for questions about metabolic syndrome was related to stroke, while the lowest was about cholesterol levels. The proportions of correct answers for selected parameters were as follows: diabetes, 39.1%; adiposity, 47.2%; hypertension, 46.8%; cholesterol levels, 36.7%; arteriosclerosis, 45.5%; myocardial infarction, 37.8%; and stroke, 62.8%. The results suggest that the level of knowledge of metabolic syndrome among the cancer survivors in our sample was poor, although more than one-third of them had metabolic syndrome. Thus, it is essential to educate cancer survivors about metabolic syndrome and its related conditions to improve their overall health and quality of life.

Chromium exposure and incidence of metabolic syndrome among American young adults over a 23-year follow-up: the CARDIA Trace Element Study

Studies suggest that chromium deficiency is associated with elevated levels of fasting blood glucose, circulating insulin, cholesterol and triglycerides, and decreased proportion of lean body mass. However, data directly relating chromium levels to metabolic syndrome (MetS) risk are lacking. A total of 3,648 American adults from the Coronary Artery Risk Development in Young Adults (CARDIA) study, aged 20-32 years, were prospectively examined for the incidence of MetS and its five components from 1987-88 to 2010-11. Baseline toenail chromium levels were measured with instrumental neutron-activation analysis. Incident MetS was defined by the NCEP-ATP III criteria. During the 23-year follow-up, 878 incident MetS cases were identified. Baseline toenail chromium was inversely associated with incidence of MetS as well as its blood lipid components. The multivariable-adjusted hazard ratio (HR) (95% confidence interval [CI]) of MetS comparing the highest to the lowest quartiles of toenail chromium levels was 0.80 (0.66-0.98; Plinear trend = 0.006). The adjusted HRs were 0.82 (0.68-0.98; Ptrend = 0.045) for having abnormal triglycerides levels and 0.75 (0.64-0.88; Ptrend  = 0.030) for having abnormal HDL cholesterol levels. Toenail chromium levels were inversely and longitudinally associated with incidence of MetS in American young adults. This inverse association was mainly explained by its relation to blood lipids.